Sirukumab and adalimumab reduce power Doppler ultrasound signal in patients with rheumatoid arthritis by 4 weeks in a phase III trial by Sweet, K, Dasgupta, B, De Vries, D, Gourley, I, Hsu, B, Loza, M, Taylor, P

Assessing therapist competence: the development of a performance-based measure and its comparison with an web-based measure by Cooper, Z, Doll, H, Bailey-Straebler, S, Bohn, K, de Vries, D, Murphy, R, O'Connor, M, Fairburn, C

Impact of filgotinib on pain control in the phase 3 FINCH studies by Taylor, PC, Kavanaugh, A, Nash, P, Pope, J, Pongratz, G, Fautrel, B, Alten, R, Hasegawa, K, Rao, S, de Vries, D, Stiers, P-J, Watson, C, Westhovens, R